Literature DB >> 7884019

The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.

T Rechlin1.   

Abstract

A total of 32 unmedicated patients with episodes of major depression (DSM-III-R) and 32 normal control subjects matched for age and sex were tested for heart rate variability (R-R variation) while resting and during deep breathing. Compared with the group of healthy subjects, the depressed patients showed no abnormalities before therapy. The patients were randomly allocated for treatment with 150 mg of amitriptyline per day (N = 8), 150 mg of doxepin per day (N = 8), 150 mg of fluvoxamine per day (N = 8), and 20 mg of paroxetine per day (N = 8). During treatment with either amitriptyline or doxepin, the coefficients of variation at rest and during deep breathing, which are largely independent of heart rate, had significantly decreased after 14 days (p = 0.012), whereas patients treated with fluvoxamine or paroxetine showed no significant changes of heart rate variability parameters after 14 days. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7884019

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  10 in total

Review 1.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

2.  Reflexes of the cutaneous microcirculation in amitriptyline and in fluoxetine treated patients.

Authors:  M Mück-Weymann; T Rechlin
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

Review 3.  Fluvoxamine versus other anti-depressive agents for depression.

Authors:  Ichiro M Omori; Norio Watanabe; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Hugh McGuire; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

4.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

Review 5.  Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis.

Authors:  Gail A Alvares; Daniel S Quintana; Ian B Hickie; Adam J Guastella
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

6.  Blunted autonomic reactivity to pharmacological panic challenge under long-term escitalopram treatment in healthy men.

Authors:  Agorastos Agorastos; Michael Kellner; Oliver Stiedl; Christoph Muhtz; Klaus Wiedemann; Cüneyt Demiralay
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-11       Impact factor: 5.176

Review 7.  Hidden Signals-The History and Methods of Heart Rate Variability.

Authors:  Gernot Ernst
Journal:  Front Public Health       Date:  2017-10-16

8.  Changes in heart rate variability of depressed patients after electroconvulsive therapy.

Authors:  Erica B Royster; Lisa M Trimble; George Cotsonis; Brian Schmotzer; Amita Manatunga; Natasha N Rushing; Giuseppe Pagnoni; S Freda Auyeung; Angelo R Brown; Joel Schoenbeck; Smitha Murthy; William M McDonald; Dominique L Musselman
Journal:  Cardiovasc Psychiatry Neurol       Date:  2012-08-27

9.  Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome.

Authors:  David Shapiro; Ian A Cook; Dmitry M Davydov; Cristina Ottaviani; Andrew F Leuchter; Michelle Abrams
Journal:  Evid Based Complement Alternat Med       Date:  2007-12       Impact factor: 2.629

10.  Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review.

Authors:  Louis T van Zyl; Takuya Hasegawa; Katsutaro Nagata
Journal:  Biopsychosoc Med       Date:  2008-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.